(BRK.A), (BRK.B)
Berkshire Hathaway’s TransRe has announced a series of leadership promotions aimed at deepening client and broker relationships while enhancing underwriting, portfolio management, and analytics capabilities across the organization.
Desmond Pollock has been appointed to lead TransRe’s Go-To-Market team, with responsibility for client and broker relationships, analytics, and market communications. Pollock joined TransRe in 2006 and previously led the U.S. Custom team. He will report to Paul McKeon, President of Global Underwriting.
Eyal Shnaps has been named head of the U.S. Custom team, a key component of TransRe’s global portfolio. Shnaps joined the company in 2014 and most recently served as Global Property Portfolio Leader. In his new role, he will report to John Fugit, Chief Underwriting Officer for North America.
Mike Torre has assumed responsibility for TransRe’s global property portfolio in addition to leading the company’s third-party capital strategy. Torre, who joined TransRe in 2018, will report to Lisa Moser, President of Global Portfolio Management.
Maryam Haji has been appointed Global Head of Research & Catastrophe Management, overseeing catastrophe management and modeling worldwide. Since joining TransRe in 2014, Haji has played a central role in advancing the firm’s risk assessment and modeling capabilities. She will continue to report to Lisa Moser.
Commenting on the changes, Paul McKeon said the promotions ensure TransRe’s front-line teams are well supported in delivering the service and expertise clients and brokers expect. Lisa Moser added that the new structure better integrates analytics with underwriting, enhancing insights across regions and lines of business.
Founded in 1977, TransRe is the brand name for Transatlantic Holdings, Inc. and its subsidiaries. A wholly owned subsidiary of Alleghany Corporation, a Berkshire Hathaway company, TransRe is headquartered in New York and operates globally, providing innovative property and casualty reinsurance solutions.
© 2026 David Mazor
Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell the stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.